MISSISSAUGA, ON, May 3, 2021 /PRNewswire/ - Nuvo
Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo
Healthcare (Miravo or the Company), a Canadian focused, healthcare
company with global reach and a diversified portfolio of commercial
products, today announced it expects to release its first quarter
2021 financial results before markets open on Monday, May 17, 2021. The Company will
review the results of the first quarter 2021 in conjunction with
the Annual Meeting of Shareholders (Meeting). The Meeting
will be held in a virtual-only format due to the continuing public
health impact of the COVID-19 pandemic and to prioritize the health
and safety of Meeting participants.
Details of the Meeting
The Meeting will take place
online via live audio webcast on Monday, May
17, 2021 at 9:00 a.m. ET at
www.virtualshareholdermeeting.com/mrv2021. Online access to
the meeting will begin at 8:45 a.m.
ET. Shareholders will not be able to attend the
Meeting in person.
Miravo's Notice of Meeting, Management Information Circular
(Circular) and the accompanying form of proxy (collectively the
Meeting Materials) were mailed on or about April 23, 2021. If you have not received
your Meeting Materials, you should contact your broker if you are a
non-registered shareholder or contact Broadridge at
proxy.request@broadridge.com, if you are a registered
shareholder. The Meeting Materials outline in detail how to
participate in the Company's virtual Meeting. For people who
would like to attend the meeting as a guest, details of the Meeting
can be found under the Company's profile on SEDAR -
www.sedar.com.
Registered Shareholders
A registered shareholder is a
shareholder who holds common shares of the Company (Common Shares)
in their own name (that is, not in the name of, or through an
Intermediary). A registered shareholder who owns Common
Shares on the Record Date (March 29,
2021) may attend the Meeting online, vote shares
electronically and submit questions during the Meeting by visiting:
www.virtualshareholdermeeting.com/mrv2021. You will need to
have your 16-digit Control Number (Control Number) that is found on
the proxy accompanying the Circular to participate in the
Meeting. If you do not have a Control Number, then you can
attend the Meeting as a guest. You can also vote your shares
in advance of the Meeting using the internet, by mail and by
telephone by following the instructions on the form of proxy.
Voting by Proxy
A registered shareholder who is unable
to attend the virtual Meeting, or does not wish to personally cast
their vote(s), may authorize another person at the Meeting to vote
on their behalf. This is known as voting by proxy.
Registered shareholders should follow the instructions on the form
of proxy enclosed with the Circular to authorize another person
(Appointee) to vote on their behalf at the Meeting. You must
provide your Appointee the exact name and eight character appointee
identification number to access the Meeting. Valid Appointees
may attend the Meeting online, vote shares electronically and
submit questions during the Meeting by visiting
www.virtualshareholdermeeting.com/mrv2021.
Attending the Meeting as a Non-Registered Holder
Only
registered holders of Common Shares, or the persons they appoint as
their proxies, are permitted to vote shares and submit questions at
the Meeting. In many cases, Common Shares beneficially owned
by a holder (Non-Registered Holder) are registered either in the
name of an Intermediary or in the name of a Depository. In
order for a Non-Registered Holder to vote their Common Shares at
the Meeting, they must carefully follow the procedures and
instructions received from the Intermediary.
Attending the Meeting as a Guest
Guests, including
Non-Registered Holders, can attend the Meeting, but will not have
the ability to ask questions or vote during the Meeting.
Guests can join the meeting by visiting:
www.virtualshareholdermeeting.com/mrv2021.
About Miravo Healthcare
Miravo is a Canadian focused,
healthcare company with global reach and a diversified portfolio of
commercial products. The Company targets several therapeutic
areas, including pain, allergy, neurology and dermatology.
The Company's strategy is to in-license and acquire
growth-oriented, complementary products for Canadian and
international markets. Miravo's head office is located in
Mississauga, Ontario, Canada, the
international operations are located in Dublin, Ireland and the Company's
manufacturing facility is located in Varennes, Québec, Canada. The
Varennes facility operates in a
Good Manufacturing Practices (GMP) environment respecting the U.S,
Canada and E.U. GMP regulations
and is regularly inspected by Health Canada and the U.S. Food and
Drug Administration. For additional information, please visit
www.miravohealthcare.com.
Technical Assistance during the Meeting
If you
encounter any difficulties accessing the virtual meeting during the
check-in or meeting time, please call the technical support number
that will be posted on the Virtual Shareholder Meeting log in
page.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-announces-first-quarter-2021-results-release-date-and-virtual-annual-meeting-of-shareholders-301282046.html
SOURCE Nuvo Pharmaceuticals Inc.